Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

582 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized clinical trial comparing long-term clopidogrel vs aspirin monotherapy beyond dual antiplatelet therapy after drug-eluting coronary stent implantation: Design and rationale of the Harmonizing Optimal Strategy for Treatment of coronary artery stenosis-Extended Antiplatelet Monotherapy (HOST-EXAM) trial.
Lee H, Koo BK, Park KW, Shin ES, Lim SW, Rha SW, Bae JW, Jeon DW, Oh SK, Hur SH, Kim BS, Lee JH, Park TH, Lee NH, Kim HS; HOST-EXAM investigators. Lee H, et al. Among authors: rha sw. Am Heart J. 2017 Mar;185:17-25. doi: 10.1016/j.ahj.2016.12.001. Epub 2016 Dec 9. Am Heart J. 2017. PMID: 28267471
A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction.
Kim JW, Seo HS, Park JH, Na JO, Choi CU, Lim HE, Kim EJ, Rha SW, Park CG, Oh DJ. Kim JW, et al. Among authors: rha sw. J Am Coll Cardiol. 2009 May 5;53(18):1653-9. doi: 10.1016/j.jacc.2009.01.051. J Am Coll Cardiol. 2009. PMID: 19406340 Free article. Clinical Trial.
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Chen KY, Rha SW, Li YJ, Poddar KL, Jin Z, Minami Y, Wang L, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim CJ, Yoon JH, Chung WS, Seung KB, Park SJ; Korea Acute Myocardial Infarction Registry Investigators. Chen KY, et al. Among authors: rha sw. Circulation. 2009 Jun 30;119(25):3207-14. doi: 10.1161/CIRCULATIONAHA.108.822791. Epub 2009 Jun 15. Circulation. 2009. PMID: 19528339 Free article.
Lack of clinical benefit of improved angiographic results with sirolimus-eluting stents compared with paclitaxel and zotarolimus-eluting stents in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Choi CU, Rha SW, Chen KY, Li YJ, Poddar KL, Jin Z, Minami Y, Suh SY, Na JO, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ. Choi CU, et al. Among authors: rha sw. Circ J. 2009 Dec;73(12):2229-35. doi: 10.1253/circj.cj-08-1086. Epub 2009 Sep 29. Circ J. 2009. PMID: 19789418 Free article.
Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry.
Li YJ, Rha SW, Chen KY, Jin Z, Minami Y, Wang L, Dang Q, Poddar KL, Ramasamy S, Park JY, Oh DJ, Jeong MH; Korea Acute Myocardial Infarction Registry Investigators. Li YJ, et al. Among authors: rha sw. Clin Exp Pharmacol Physiol. 2010 May;37(5-6):581-6. doi: 10.1111/j.1440-1681.2010.05363.x. Epub 2010 Jan 25. Clin Exp Pharmacol Physiol. 2010. PMID: 20105192 Clinical Trial.
Duration of dual antiplatelet therapy after implantation of drug-eluting stents.
Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW, Han KH, Park SW, Yun SC, Lee SG, Rha SW, Seong IW, Jeong MH, Hur SH, Lee NH, Yoon J, Yang JY, Lee BK, Choi YJ, Chung WS, Lim DS, Cheong SS, Kim KS, Chae JK, Nah DY, Jeon DS, Seung KB, Jang JS, Park HS, Lee K. Park SJ, et al. Among authors: rha sw. N Engl J Med. 2010 Apr 15;362(15):1374-82. doi: 10.1056/NEJMoa1001266. Epub 2010 Mar 15. N Engl J Med. 2010. PMID: 20231231 Free article. Clinical Trial.
Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.
Li YJ, Rha SW, Chen KY, Poddar KL, Jin Z, Minami Y, Wang L, Dang Q, Li GP, Ramasamy S, Park JY, Choi CU, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ, Jeong MH, Ahn YK, Hong TJ, Park JS, Kim YJ, Hur SH, Seong IW, Chae JK, Cho MC, Bae JH, Choi DH, Jang YS, Chae IH, Kim HS, Kim CJ, Yoon JH, Ahn TH, Tahk SJ, Chung WS, Seung KB, Park SJ; other Korea Acute Myocardial infarction Registry Investigators. Li YJ, et al. Among authors: rha sw. Am Heart J. 2010 Apr;159(4):684-690.e1. doi: 10.1016/j.ahj.2009.12.041. Am Heart J. 2010. PMID: 20362730 Clinical Trial.
Paclitaxel- versus sirolimus-eluting stents for treatment of ST-segment elevation myocardial infarction: with analyses for diabetic and nondiabetic subpopulation.
Cho Y, Yang HM, Park KW, Chung WY, Choi DJ, Seo WW, Jeong KT, Chae SC, Lee MY, Hur SH, Chae JK, Seong IW, Yoon JH, Oh SK, Kim DI, Park KS, Rha SW, Jang YS, Bae JH, Hong TJ, Cho MC, Kim YJ, Jeong MH, Kim MJ, Park SK, Chae IH, Kim HS; KAMIR Investigators. Cho Y, et al. Among authors: rha sw. JACC Cardiovasc Interv. 2010 May;3(5):498-506. doi: 10.1016/j.jcin.2010.02.011. JACC Cardiovasc Interv. 2010. PMID: 20488406 Free article.
582 results